Global Clinical Trial Exceeds Expectations
A global pharmaceutical company working to bring a revolutionary medical application to market was significantly behind their main competitor in the development process. To further complicate matters, the company had completely outsourced the project to a CRO for the first time. Control and communication issues added to the already complex project.
The team committed to significantly reduce the cycle time of the clinical trial, specifically exceeding their patient recruitment target. They also created the possibility of significantly expanding the number of countries they were recruiting in for clinical trials. Furthermore, they expanded the trial by creating the utilization of the device for other drug indications as well.
The team surpassed expectations in both with the clinical trial and the leadership development of the people on the team. The original recruitment target was 600 patients; they enrolled 798 patients globally, moving from being significantly behind, to 133% of their target for enrolling patients into the study.